BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/25/2025 4:19:19 PM | Browse: 174 | Download: 963
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 103843
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Basic Study
Article Title Nitric oxide synthase 1 inhibits progression of esophageal cancer through interacting with nitric oxide synthase 1 adaptor protein
Manuscript Source Unsolicited Manuscript
All Author List Zi-Wei Xiao, Ying-Chao Zeng, Lin-Tao Ji, Jia-Tao Yuan and Lin Li
ORCID
Author(s) ORCID Number
Lin Li http://orcid.org/0009-0002-7763-4733
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China No. 81000201
Corresponding Author Lin Li, Associate Professor, College of Medical, Hunan Normal University, No. 36 Lushan Road, Changsha 410081, Hunan Province, China. 18529482372@163.com
Key Words Nitric oxide synthase 1; Nitric oxide synthase 1 adaptor protein; Autophagy; Phosphatidylinositol 3-kinase/protein kinase B pathway; Esophageal cancer
Core Tip Nitric oxide synthase 1 (NOS1) inhibits the proliferation, metastasis, apoptosis, pyroptosis, and ferroptosis of esophageal cancer (ESCA) cells, enhances the autophagy, and effectively delays the onset of ESCA in a nude mouse xenograft model. Mechanistically, NOS1 interacts with the NOS1 adaptor protein, inhibiting the activation of the phosphatidylinositol 3-kinase/protein kinase B pathway. Both in vitro and in vivo studies suggest that NOS1 represents a potential therapeutic target for ESCA.
Publish Date 2025-03-25 16:19
Citation

Xiao ZW, Zeng YC, Ji LT, Yuan JT, Li L. Nitric oxide synthase 1 inhibits progression of esophageal cancer through interacting with nitric oxide synthase 1 adaptor protein. World J Gastrointest Oncol 2025; 17(4): 103843

URL https://www.wjgnet.com/1948-5204/full/v17/i4/103843.htm
DOI https://dx.doi.org/10.4251/wjgo.v17.i4.103843
Full Article (PDF) WJGO-17-103843-with-cover.pdf